Physician profile
Linh DO
NPI 1073976114
$10,810.71
in general payments reported to CMS, 2019-2025
28 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what 75% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $137 · 2023: $5,533 · 2024: $3,632 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,575 · Travel and Lodging: $3,755 · Education: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,575.02 |
| Travel and Lodging | $3,755.20 |
| Education | $1,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,361.56 | 2022-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $2,304.43 | 2023 | Da Vinci Surgical System, Davinci Xi |
| Coloplast Corp | $1,793.02 | 2023-2025 | Altis |
| Boston Scientific Corporation | $1,512.90 | 2021-2025 | Solyx Sis System, Spaceoar Vue System - 10ml |
| Medtronic, INC. | $1,289.56 | 2021-2025 | Interstim |
| Sumitomo Pharma America, INC. | $363.00 | 2023-2025 | Gemtesa, Orgovyx |
| Progenics Pharmaceuticals, INC. | $144.99 | 2023-2025 | Pylarify |
| Teleflex LLC | $115.33 | 2024 | Solesta, Urolift |
| Abbvie INC. | $97.00 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.58 | 2025 | |
| Dendreon Pharmaceuticals LLC | $84.48 | 2024-2025 | Provenge |
| Astrazeneca Pharmaceuticals LP | $65.15 | 2024 | |
| Coopersurgical, INC. | $61.91 | 2024 | Wallach Cryosurgical Equipment |
| Myriad Genetic Laboratories, INC. | $57.40 | 2024-2025 | Prolaris |
| Verity Pharmaceuticals INC. | $51.41 | 2025 | Trelstar, Tlando |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Femselect INC. | $50.88 | 2024 | Enplace |
| Merck Sharp & Dohme LLC | $48.50 | 2024 | Keytruda |
| Janssen Biotech, INC. | $43.88 | 2025 | Erleada |
| Caldera Medical, INC | $32.93 | 2023 | Desara |
| Biomarin Pharmaceutical INC. | $31.28 | 2025 | Voxzogo 1.2mg |
| Abc Home Medical Supply, INC. | $30.61 | 2025 | |
| Novo Nordisk INC | $30.48 | 2024 | Rivfloza |
| Polynovo North America LLC | $30.28 | 2025 | Novosorb Btm |
| Bluewind Medical | $26.96 | 2025 | Revi |
| Ethicon US, LLC | $26.49 | 2025 | Enseal, Echelon; Endopath |
| Dilon Technologies, INC. | $22.27 | 2025 | Hemoblast Bellows |
| Cook Medical LLC | $19.32 | 2024 | Ncircle |
| Antares Pharma, INC. | $19.11 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linh DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.